ERBB2 and neoplasm: Aggressive tumor biology and corresponding poorer prognosis is associated with amplification or overexpression of HER2, a transmembrane tyrosine kinase protein belonging to the human epidermal growth factor receptor (EGFR) family of proteins [9].